The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.

Debrix, I; Tilleul, P; Milleron, B; Grené, N; Bouleuc, C; Roux, D; Lioté, H; Madelaine, I; Bellanger, A; Conort, O; Fontan, J E; Le Mercier, F; Bardin, C; Becker, A

Debrix, I; Tilleul, P; Milleron, B; Grené, N; Bouleuc, C; Roux, D; Lioté, H; Madelaine, I; Bellanger, A; Conort, O; Fontan, J E; Le Mercier, F; Bardin, C; Becker, A.

Affiliation

Debrix I; Service de Pharmacie-Toxicologie, Comité Local du Médicament, Hjpital Tenon, Paris, France. isabelle.debrix@tnn.ap-hp-paris.fr

Clin Ther ; 23(7): 1116-27, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11519774

Subject(s)

Colony-Stimulating Factors/therapeutic use; Medical Oncology; Neoplasms/drug therapy; Oncology Service, Hospital; Practice Guidelines as Topic; Societies, Medical; Humans; Paris; Patient Care Team; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Societies, Medical / Colony-Stimulating Factors / Oncology Service, Hospital / Practice Guidelines as Topic / Medical Oncology / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte / Europa Language: En Journal: Clin Ther Year: 2001 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links